{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:37:31Z","timestamp":1783766251709,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chen Xiao-ping Foundation for the Development of Science and Techonology of Hubei Province","award":["No. CXPJJH122011-011"],"award-info":[{"award-number":["No. CXPJJH122011-011"]}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping medical foundation","doi-asserted-by":"crossref","award":["No. 320.6750.2023-18-21"],"award-info":[{"award-number":["No. 320.6750.2023-18-21"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81335-9","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T11:05:56Z","timestamp":1733223956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploring an novel diagnostic gene of trastuzumab-induced cardiotoxicity based on bioinformatics and machine learning"],"prefix":"10.1038","volume":"14","author":[{"given":"Jixiang","family":"Pei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qitang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"issue":"5","key":"81335_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller, K. D. et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J. Clin. 72(5), 409\u2013436. https:\/\/doi.org\/10.3322\/caac.21731 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"81335_CR2","doi-asserted-by":"publisher","unstructured":"GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010\u201319: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 400(10352), 563\u2013591. https:\/\/doi.org\/10.1016\/S0140-6736(22)01438-6 (2022).","DOI":"10.1016\/S0140-6736(22)01438-6"},{"key":"81335_CR3","doi-asserted-by":"publisher","unstructured":"Global Burden of Disease 2019 Cancer Collaboration, Kocarnik, J. M., Compton, K. et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 8(3), 420\u2013444. https:\/\/doi.org\/10.1001\/jamaoncol.2021.6987 (2022).","DOI":"10.1001\/jamaoncol.2021.6987"},{"key":"81335_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.821663","volume":"8","author":"M Lin","year":"2022","unstructured":"Lin, M. et al. The research progress of trastuzumab-induced cardiotoxicity in HER-2-positive breast cancer treatment. Front. Cardiovasc. Med. 8, 821663. https:\/\/doi.org\/10.3389\/fcvm.2021.821663 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"81335_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.25259\/IJPP_390_2021","volume":"66","author":"D Kumar","year":"2022","unstructured":"Kumar, D., Basu, S., Goyal, R. K., Sahoo, P. K. & Mathur, R. Comparison of adverse effects of trastuzumab with other drug combinations for the treatment of breast cancer: a review. Indian J. Physiol. Pharmacol. 66, 1\u201315. https:\/\/doi.org\/10.25259\/IJPP_390_2021 (2022).","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"81335_CR6","doi-asserted-by":"publisher","unstructured":"Lyon, A. R., L\u00f3pez-Fern\u00e1ndez, T., Couch, L. S. et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) [published correction appears in Eur Heart J Cardiovasc Imaging. 2023 May 31;24(6):e98]. Eur. Heart J. Cardiovasc. Imaging 23(10), e333\u2013e465. https:\/\/doi.org\/10.1093\/ehjci\/jeac106 (2022).","DOI":"10.1093\/ehjci\/jeac106"},{"issue":"10191","key":"81335_CR7","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1016\/S0140-6736(19)30650-6","volume":"393","author":"HM Earl","year":"2019","unstructured":"Earl, H. M. et al. 6 versus 12 months of adjuvant Trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. Lancet 393(10191), 2599\u20132612. https:\/\/doi.org\/10.1016\/S0140-6736(19)30650-6 (2019).","journal-title":"Lancet"},{"issue":"1","key":"81335_CR8","first-page":"1005","volume":"2","author":"N Mohan","year":"2017","unstructured":"Mohan, N., Jiang, J. & Wu, W. J. Implications of autophagy and oxidative stress in trastuzumab-mediated cardiac toxicities. Austin Pharmacol. Pharm. 2(1), 1005 (2017).","journal-title":"Austin Pharmacol. Pharm."},{"key":"81335_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121207","volume":"312","author":"J Min","year":"2023","unstructured":"Min, J. et al. Empagliflozin attenuates trastuzumab-induced cardiotoxicity through suppression of DNA damage and ferroptosis. Life Sci. 312, 121207. https:\/\/doi.org\/10.1016\/j.lfs.2022.121207 (2023).","journal-title":"Life Sci."},{"key":"81335_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.870924","volume":"9","author":"R Chai","year":"2022","unstructured":"Chai, R. et al. Cardiac remodeling in heart failure: role of pyroptosis and its therapeutic implications. Front. Cardiovasc. Med. 9, 870924. https:\/\/doi.org\/10.3389\/fcvm.2022.870924 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"81335_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2023.100268","volume":"78","author":"Z Su","year":"2023","unstructured":"Su, Z. et al. Trastuzumab-induced human cardiomyocyte damage through the Notch2\/JAK2\/STAT3 pathway. Clinics (Sao Paulo) 78, 100268. https:\/\/doi.org\/10.1016\/j.clinsp.2023.100268 (2023).","journal-title":"Clinics (Sao Paulo)"},{"issue":"8","key":"81335_CR12","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41576-023-00580-2","volume":"24","author":"K Vandereyken","year":"2023","unstructured":"Vandereyken, K., Sifrim, A., Thienpont, B. & Voet, T. Methods and applications for single-cell and spatial multi-omics. Nat. Rev. Genet. 24(8), 494\u2013515. https:\/\/doi.org\/10.1038\/s41576-023-00580-2 (2023).","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"81335_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/07388550600978358","volume":"26","author":"I Barbulovic-Nad","year":"2006","unstructured":"Barbulovic-Nad, I. et al. Bio-microarray fabrication techniques\u2014a review. Crit. Rev. Biotechnol. 26(4), 237\u2013259. https:\/\/doi.org\/10.1080\/07388550600978358 (2006).","journal-title":"Crit. Rev. Biotechnol."},{"issue":"12","key":"81335_CR14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41577-018-0065-8","volume":"18","author":"FK Swirski","year":"2018","unstructured":"Swirski, F. K. & Nahrendorf, M. Cardioimmunology: the immune system in cardiac homeostasis and disease. Nat. Rev. Immunol. 18(12), 733\u2013744. https:\/\/doi.org\/10.1038\/s41577-018-0065-8 (2018).","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"81335_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41392-020-00455-6","volume":"6","author":"K Sun","year":"2021","unstructured":"Sun, K., Li, Y. Y. & Jin, J. A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair. Signal Transduct. Target. Ther. 6(1), 79. https:\/\/doi.org\/10.1038\/s41392-020-00455-6 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"81335_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3390\/jcdd10120489","volume":"10","author":"SE Slavcheva","year":"2023","unstructured":"Slavcheva, S. E. & Angelov, A. HER2-targeted therapy-from pathophysiology to clinical manifestation: a narrative review. J. Cardiovasc. Dev. Dis. 10(12), 489. https:\/\/doi.org\/10.3390\/jcdd10120489 (2023).","journal-title":"J. Cardiovasc. Dev. Dis."},{"issue":"9","key":"81335_CR17","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.7150\/ijbs.26215","volume":"14","author":"Y Dong","year":"2018","unstructured":"Dong, Y. et al. Non-coding RNA-linked epigenetic regulation in cardiac hypertrophy. Int. J. Biol. Sci. 14(9), 1133\u20131141. https:\/\/doi.org\/10.7150\/ijbs.26215 (2018).","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"81335_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2), 281\u2013297. https:\/\/doi.org\/10.1016\/s0092-8674(04)00045-5 (2004).","journal-title":"Cell"},{"issue":"2","key":"81335_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/cvr\/cvz108","volume":"116","author":"G Milano","year":"2020","unstructured":"Milano, G. et al. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin\/Trastuzumab-induced cardiac toxicity. Cardiovasc. Res. 116(2), 383\u2013392. https:\/\/doi.org\/10.1093\/cvr\/cvz108 (2020).","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"81335_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7), e47. https:\/\/doi.org\/10.1093\/nar\/gkv007 (2015).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"81335_CR21","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51(D1), D638\u2013D646. https:\/\/doi.org\/10.1093\/nar\/gkac1000 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"43","key":"81335_CR22","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102(43), 15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"81335_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5), 284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118 (2012).","journal-title":"OMICS"},{"issue":"17","key":"81335_CR24","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/bioinformatics\/btv300","volume":"31","author":"W Walter","year":"2015","unstructured":"Walter, W., S\u00e1nchez-Cabo, F. & Ricote, M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics 31(17), 2912\u20132914. https:\/\/doi.org\/10.1093\/bioinformatics\/btv300 (2015).","journal-title":"Bioinformatics"},{"key":"81335_CR25","doi-asserted-by":"publisher","unstructured":"Warde-Farley, D., Donaldson, S. L., Comes, O. et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 38(Web Server issue), W214\u2013W220. https:\/\/doi.org\/10.1093\/nar\/gkq537 (2010).","DOI":"10.1093\/nar\/gkq537"},{"key":"81335_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random Forests. Mach. Learn. 45, 5\u201332 (2001).","journal-title":"Mach. Learn."},{"issue":"10270","key":"81335_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0140-6736(20)32519-8","volume":"397","author":"F D'Ascenzo","year":"2021","unstructured":"D\u2019Ascenzo, F. et al. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets. Lancet 397(10270), 199\u2013207. https:\/\/doi.org\/10.1016\/S0140-6736(20)32519-8 (2021).","journal-title":"Lancet"},{"key":"81335_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani, R. Regression shrinkage and selection via the lasso. J. R. Stat. Soc. B 58, 267\u2013288 (1996).","journal-title":"J. R. Stat. Soc. B"},{"key":"81335_CR29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 9, 559. https:\/\/doi.org\/10.1186\/1471-2105-9-559 (2008).","journal-title":"BMC Bioinform."},{"issue":"11","key":"81335_CR30","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13(11), 2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303 (2003).","journal-title":"Genome Res."},{"key":"81335_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 12, 77. https:\/\/doi.org\/10.1186\/1471-2105-12-77 (2011).","journal-title":"BMC Bioinform."},{"key":"81335_CR32","unstructured":"Harrell, F. E. rms: regression modeling sTrategies, R package version 5.1-2 (Dept. Biostatist., Vanderbilt Univ., 2017)."},{"key":"81335_CR33","doi-asserted-by":"publisher","unstructured":"Kang, J., Tang, Q., He, J. et al. RNAInter v4.0: RNA interactome repository with redefined confidence scoring system and improved accessibility. Nucleic Acids Res. 50(D1), D326\u2013D332. https:\/\/doi.org\/10.1093\/nar\/gkab997 (2022).","DOI":"10.1093\/nar\/gkab997"},{"issue":"2","key":"81335_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gpb.2019.09.006","volume":"18","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. hTFtarget: a comprehensive database for regulations of human transcription factors and their targets. Genom. Proteom. Bioinform. 18(2), 120\u2013128. https:\/\/doi.org\/10.1016\/j.gpb.2019.09.006 (2020).","journal-title":"Genom. Proteom. Bioinform."},{"key":"81335_CR35","doi-asserted-by":"publisher","unstructured":"Tokar, T., Pastrello, C., Rossos, A. E. M,. et al. mirDIP 4.1-integrative database of human microRNA target predictions. Nucleic Acids Res. 46(D1), D360\u2013D370. https:\/\/doi.org\/10.1093\/nar\/gkx1144 (2018).","DOI":"10.1093\/nar\/gkx1144"},{"issue":"1","key":"81335_CR36","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18(1), 220. https:\/\/doi.org\/10.1186\/s13059-017-1349-1 (2017).","journal-title":"Genome Biol."},{"key":"81335_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115662","volume":"214","author":"S Wei","year":"2023","unstructured":"Wei, S. et al. Trastuzumab potentiates doxorubicin-induced cardiotoxicity via activating the NLRP3 inflammasome in vivo and in vitro. Biochem. Pharmacol. 214, 115662. https:\/\/doi.org\/10.1016\/j.bcp.2023.115662 (2023).","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"81335_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/annonc\/mdq397","volume":"22","author":"S Guiu","year":"2011","unstructured":"Guiu, S. et al. Long-term follow-up of HER2-overexpressing stage II or III breast cancer treated by anthracycline-free neoadjuvant chemotherapy. Ann. Oncol. 22(2), 321\u2013328. https:\/\/doi.org\/10.1093\/annonc\/mdq397 (2011).","journal-title":"Ann. Oncol."},{"issue":"21","key":"81335_CR39","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1111\/bph.13643","volume":"174","author":"BT Nemeth","year":"2017","unstructured":"Nemeth, B. T., Varga, Z. V., Wu, W. J. & Pacher, P. Trastuzumab cardiotoxicity: from clinical trials to experimental studies. Br. J. Pharmacol. 174(21), 3727\u20133748. https:\/\/doi.org\/10.1111\/bph.13643 (2017).","journal-title":"Br. J. Pharmacol."},{"issue":"18","key":"81335_CR40","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo, M. et al. DSigDB: drug signatures database for gene set analysis. Bioinformatics 31(18), 3069\u20133071. https:\/\/doi.org\/10.1093\/bioinformatics\/btv313 (2015).","journal-title":"Bioinformatics"},{"issue":"W1","key":"81335_CR41","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44(W1), W90\u2013W97. https:\/\/doi.org\/10.1093\/nar\/gkw377 (2016).","journal-title":"Nucleic Acids Res."},{"key":"81335_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4615-3436-5_1","volume":"315","author":"J Sturman","year":"1992","unstructured":"Sturman, J. Review: taurine deficiency and the cat. Adv. Exp. Med. Biol. 315, 1\u20135. https:\/\/doi.org\/10.1007\/978-1-4615-3436-5_1 (1992).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9","key":"81335_CR43","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300272R","volume":"37","author":"C Li","year":"2023","unstructured":"Li, C. et al. Deficiency of Pdk1 drives heart failure by impairing taurine homeostasis through Slc6a6. FASEB J. 37(9), e23134. https:\/\/doi.org\/10.1096\/fj.202300272R (2023).","journal-title":"FASEB J."},{"key":"81335_CR44","doi-asserted-by":"publisher","unstructured":"Garnier, S., Harakalova, M., Weiss, S. et al. Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23 [published correction appears in Eur Heart J. 2021 May 21;42(20):2011]. Eur. Heart J. 42(20), 2000\u20132011. https:\/\/doi.org\/10.1093\/eurheartj\/ehab030 (2021).","DOI":"10.1093\/eurheartj\/ehab030"},{"issue":"4","key":"81335_CR45","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/hmg\/ddz303","volume":"29","author":"M Ansar","year":"2020","unstructured":"Ansar, M. et al. Taurine treatment of retinal degeneration and cardiomyopathy in a consanguineous family with SLC6A6 taurine Transporter deficiency. Hum. Mol. Genet. 29(4), 618\u2013623. https:\/\/doi.org\/10.1093\/hmg\/ddz303 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"81335_CR46","doi-asserted-by":"publisher","unstructured":"Mele, A., Mantuano, P., De Bellis, M. et al. A long-term treatment with taurine prevents cardiac dysfunction in mdx mice [published correction appears in Transl Res. 2020 Sep;223:107]. Transl. Res. 204, 82\u201399. https:\/\/doi.org\/10.1016\/j.trsl.2018.09.004 (2019).","DOI":"10.1016\/j.trsl.2018.09.004"},{"issue":"Pt A","key":"81335_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107071","volume":"89","author":"L Peng","year":"2020","unstructured":"Peng, L., Chen, Y., Ou, Q., Wang, X. & Tang, N. LncRNA MIAT correlates with immune infilTrates and drug reactions in hepatocellular carcinoma. Int. Immunopharmacol. 89(Pt A), 107071. https:\/\/doi.org\/10.1016\/j.intimp.2020.107071 (2020).","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"81335_CR48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12985-017-0695-7","volume":"14","author":"YF Xia","year":"2017","unstructured":"Xia, Y. F. et al. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA. Virol. J. 14(1), 20. https:\/\/doi.org\/10.1186\/s12985-017-0695-7 (2017).","journal-title":"Virol. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81335-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81335-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81335-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T12:06:44Z","timestamp":1733227604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81335-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["81335"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81335-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"7 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All the animal experimenters involved in this project have passed the animal experiment operation assessment and strictly abide by the animal welfare ethical requirements of Qingdao University. The approval number is 20240628C571520240720064.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics committee approval"}}],"article-number":"30067"}}